Clinical Trials Directory

Trials / Completed

CompletedNCT04203836

A Trial to Evaluate the Effect of Food on LEO 152020

A Phase 1, Randomised, Oral Dose Trial to Evaluate the Effect of Food on LEO 152020 in Healthy Adult Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
12 (actual)
Sponsor
JW Pharmaceutical · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

A phase 1 trial in healthy people to evaluate the food effect on LEO 152020 in an open-label design using film-coated tablets

Detailed description

This trial will evaluate the pharmacokinetics and tolerability of 2 single doses of film-coated tablets in the morning after fasting or after a high-fat breakfast. The 2 doses will be separated by a washout period.

Conditions

Interventions

TypeNameDescription
DRUGLEO 152020 Tabletfilm-coated tablet

Timeline

Start date
2020-01-09
Primary completion
2020-12-12
Completion
2020-12-12
First posted
2019-12-18
Last updated
2024-04-22

Locations

2 sites across 2 countries: United States, United Kingdom

Source: ClinicalTrials.gov record NCT04203836. Inclusion in this directory is not an endorsement.

A Trial to Evaluate the Effect of Food on LEO 152020 (NCT04203836) · Clinical Trials Directory